e-Drug3D

1170

NIMODIPINE


INN
NIMODIPINE

cas 66085-59-4
CLASS

CARDIOVASCULAR
VASODILATOR
CALCIUM CHANNEL ANTAGONIST
ANTIHYPERTENSIVE AGENTS

ROUTE (list)

ORAL

ATC code

C08CA06

PK parameters

F 13 PERCENT
Tmax 1 HOUR
VD 66 LITER
Cl 54 LITER / HOUR
PPB 95 PERCENT
t1/2 1.5 HOUR

Solubility

PRACTICALLY INSOLUBLE IN WATER


Target

TARGET CALCIUM CHANNEL

DrugCentral

Voltage-dependent L-type calcium channel subunit alpha-1C UNIPROT Q13936 CACNA1C

Voltage-dependent L-type calcium channel subunit alpha-1D UNIPROT Q01668 CACNA1D

Download SDF file O5-(2-methoxyethyl) O3-propan-2-yl 2,6-dimethyl-4-(3-nitrophenyl)-1,4-dihydropyridine-3,5-dicarboxylate

Formula:
C21H26N2O7

Calculated chemical properties:

MW 418.44
NB_atoms 30
XLogP 0
PSA 106.51
NB_HD 1
NB_HA 8
fsp3 0.43
Lipinski(0=no;1=yes) 1

FDA
NDA 018869 (label) INN (NIMODIPINE) NIMOTOP (BAYER PHARMS) APPROVAL= AP YEAR= 1988 DISCONTINUED
NDA 077067 (pdf not found) INN (NIMODIPINE) NIMODIPINE (SUN PHARM INDS INC) APPROVAL= AP YEAR= 2007 DISCONTINUED
NDA 077811 (pdf not found) INN (NIMODIPINE) NIMODIPINE (HERITAGE) APPROVAL= AP YEAR= 2007
NDA 076740 (pdf not found) INN (NIMODIPINE) NIMODIPINE (BIONPHARMA) APPROVAL= AP YEAR= 2008
NDA 203340 (label) INN (NIMODIPINE) NYMALIZE (AZURITY) APPROVAL= AP YEAR= 2013
NDA 090103 (pdf not found) INN (NIMODIPINE) NIMODIPINE (THEPHARMANETWORK LLC) APPROVAL= AP YEAR= 2014
NDA 201832 (pdf not found) INN (NIMODIPINE) NIMODIPINE (SOFGEN PHARMS) APPROVAL= AP YEAR= 2015 DISCONTINUED
NDA 216937 (pdf not found) INN (NIMODIPINE) NIMODIPINE (ANNORA PHARMA) APPROVAL= AP YEAR= 2024
NDA 213409 (pdf not found) INN (NIMODIPINE) NIMODIPINE (ALKEM LABS LTD) APPROVAL= AP YEAR= 2025

Other links:

PubChem
ChemicalProbes

U.S. repository of Clinical Trials

VigiAccess
SIDER side effects

ChemSynthesis
Patent@SureChEMBL